NEU 2.90% $19.86 neuren pharmaceuticals limited

Ann: Notice of Annual General Meeting/Proxy Form, page-39

  1. 420 Posts.
    lightbulb Created with Sketch. 471
    Hottod, Great analysis. It would be very interesting to see the value of the end markets in relation to the deals you mention compared with Neuren's end markets. This would put some further perspective on the numbers.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.